November 22, 2006Typically OutrageousI've long bitched about how costly psych meds are, especially the atypical antipsychotics, which are used in treating schizophrenia, bipolar disorder and, should AstraZeneca get its way, every other DSM category under the sun. Now, CL Psych has a post on his blog about how vast the cost difference is between older and newer antipsychotiocs. The media commonly reports that this difference is 10 times, basing that upon claims that were floated last year about the time the CATIE study came out. What he's found is that the difference is anywhere from about 8 times to 20 times the cost of older atypicals for comparable doses. That's an outrage. In no way are the newer meds so much better than the older meds as to justify such a price differential. I guess patients and taxpayers are to pay for pharma companies' research costs. Why haven't MHA and NAMI made this an issue at all? Could this have anything to do with the funding they receive from pharma companies? And, if the fine folks at the Treatment Advocacy Center truly believe in their forced medication ideology, then why aren't they making this an issue? Psych patients are in no position to force a free market for antipsychotics. It's time that the advocacy groups woke up and started doing work that will impact the life of millions of schizophrenics and bipolars. Posted by Philip Dawdy at November 22, 2006 08:11 AM
del.icio.us
Digg it
reddit
Comments
You wrote: "Psych patients are in no position to force a free market for antipsychotics." You're right, but for a different reason. Atypicals are expensive, but the solution isn't to force them to be less expensive, or price caps, etc, etc. If they truly aren't better than the older drugs, then psychiatrists simply shouldn't be prescribing them- as much- and THEREFORE the price will fall as Pharma attempts to recoup some money. (Demand becomes elastic.) The problem is that psychiatrists prescribe these medicines (for various reasons, some good, some bad) with no mind to the cost. But IF psychiatrists were forced to consider cost as a factor (say, a pharmacy budget per patient rather than formulary restrictions) then they would have to be more judicious about "expensive" drugs, and more attentive to the literature about their efficacy and side effects. In other words, they'd have to be more rigorous about whether a drug is worth the money. In this scenario, Pharma will have no choice but to reduce their costs, and they will also not have the incentive to create "me too" drugs. And simple efficacy comparisons won't be enough. For example, say Seroquel and Haldol have the same efficacy. Seroquel is more expensive then Haldol; but is Seroquel more expensive than Haldol + cogentin + ambien? etc, etc.
Real life numbers from many medications that have been bought and paid for in the last year for either my daughter or myself, one month supply, based on no insurance. I am fortunate to have insurance, and my daughter has medical coupons. Lithium Carb 300mg caps $50.43 Haldol $40.10 Zyprexa 10 mg tabs $755.04 (Look at that price on Zyprexa!) Zyprexa 5mg tabs 253.89 Prozac 10 mg caps 25.21 Cogentin 1 mg tabs 10.68 Seroquel 25mg tabs 77.22 Xanax (brand name, not generic) 1mg XR= $122.49 One doctor has my daughter on the Haldol/10 mg Tabs combo=$845.57 per month(that does not include the prescription benedryl she was on as well.) Another combo from another doc included Prozac/ 5 mg Zyprexa tabs/Cogentin=$289.78 per month. One of the worst 5 medication discharges we had from another doc included trileptal, as well as 200mg tabs of Seroquel, I can't find those pharma receipts right now, but the above listings should put some of this into perspective. My daughter currently is on Clozaril and I will be looking into the price on that one, I don't have the paperwork here. She takes Clozaril, Lithium and Cogentin right now as her primary medications. She took Zyprexa for over 6 straight years, and sometimes at higher doses.The higher the dose, the more expensive. Looking at the list of meds I listed here, it is fairly easy to find a typical combo of meds a person may be taking and do the math. If a person does not have insurance then what? This is what happens to many mental health patients/consumers on low to no income: they don't get treatment, because they cannot afford their medications. To know if a medicated population is doing well, it is imperative to get every one equal access to medications. Otherwise all the studies in the world can never have adequate numbers to back up their claims of efficacy. Note that the least expensive medications were given to my daughter at county facilities. Zyprexa , one of the most expensive antipsychotics was given to her in the State Hospital. All of the agencies have contracts for medications, and you will often see patients come out of an institution on over-priced meds such as Zyprexa, only to be tossed into the low-income support services in this state at least, and then not be able to afford those medications. Now ask yourself why patients stop taking meds and or seek treatment? Using Lithium Carb caps/10mg Zyprexa/Cogentin as a typical combo example per month: $816.15 Posted by: Stephany at November 23, 2006 07:29 AMOne more comment regarding "giving the doctor a budget within he must operate." The doctor needs to start with him/herself. The 130.00-$150.00 per 30 minute charges are outrageous, some docs charge that for 15 minutes. My daughter's outpatient psychiatrist no longer accepts any insurance. I have to manually submit the claim for a 60% payback. Until the psychiatrists themselves get in this same thought pattern of low cost medications,and what they charge for services then it is like driving a car with 3 wheels. Sadly, I feel reform will not happen, because it is such a lucrative market. Posted by: Stephany at November 23, 2006 07:58 AMThe evidence is mounting that the knee-jerk assumption that atypicals should be the first line medication for treatment of psychoses is diminishing. Thanks to the Pharma funded medication algorithms, the switch has largely been made to atypicals in the public mental health system. But, it has been very costly. For example, the Medicaid expenditures for antipsychotics increased 160% between 1995 and 1998 when the total number of prescriptions only increased 20%. That is because the proportion of atypical prescriptions grew from 17.5% in 1995 to 51% 3 years later in 1998. The cost grew as well, from $487 million in 1995 to $1.3 billion in 1998. Imagine how much more of the pie the pharmaceutical companies are getting now, 8 years and many marketing dollars later. Also imagine if that money were available for services, such as medication education and close monitoring for efficacy and side-effects. Decisions about medication should be based on efficacy and side-effects, not classification alone. And Clozapine shouldn’t be abandoned just because it is off-patent and isn’t being marketed by the Big Pharma reps. If money were freed up for better medication management services, clinicians would be in a better position to evaluate efficacy and side-effects and make more informed prescribing decisions. This is from TAC's blog, Aug. 4, 2006. They have been speaking out about the cost of meds for a long time. Thanks for your blog, I read it very often. Posted by: Joanne at November 28, 2006 08:46 AM |
Patient Blogs. Sites.
The Trouble With Spikol
Icarus Project Blog John's Bipolar Stories Seroxat (Paxil) Sufferers Stand Up! Seroxat (Paxil) Secrets The Bipolar View Writhe Safely soulful sepulcher Electro Boy Spiritual Emergency Mental Nurse Deborah Gray Mental Mommy The Splintered Mind bipolar.and.me Nurse Ratched Psych Person Trick Cycling for Beginners depression introspection Salted Lithium Living With A Purple Dog Polar Trippin' Mercurial Scribe Bipolar Chicks Blogging Beyond Meds Off Label Jung At Heart Graphic Truth Joysoup Apesma's Lament Soapy Water Outlaw Psychiatry Empirical Insanity Patient Anonymous Beyond Blue Psych Survivor Postpartum Progress The Happiness Project Finding Optimism The Gimp Parade Midlife and Treachery Secret Life of a Manic-Depressive Psych Tech Going Through Hell
Doctor Blogs. Sites.
Clinical Psych
World of Psychology CorePsych The Last Psychiatrist Carlat Report Blog Intueri Emotional Well-Being Scientific Misconduct Aaron Beck Cognitive Therapy Today Treatment Online Shrink Rap David Healy Dr. Dork NHS Blog Doctor Dr. X's Free Associations Dr. Sanity Anxious Mind Everyone Needs Therapy Counselling Resource
Activists. News.
Charlottesville Prejudice Watch
The Icarus Project MindFreedom AHRP Blog SSRI Stories Healthy Skepticism Psych Rights Treatment Advocacy Center Peter Breggin Schizophrenia News eDrugSearch Blog Nuts R Us News Disapedia WSJ Health Blog Alison Bass
Social Networking. Forums.
Beyond Meds Social Network
Mood Garden Paxil Progress Crazy Boards Forums Psych Central Forums Icarus Project Forums DepressionTribe MySpace Bipolar Group Bipolar World Pendulum.org Bipolar Planet About.com Bipolar
Science. Big Pharma. Ethics.
PharmaLot
Pharma Gossip Science Blogs Mind Hacks GoozNews Integrity in Science Neurophilospohy bioethics.net Drug Wonks Pharma Marketing Blog Pharma's Cutting Edge On Pharma Health Care Renewal
Current Affairs
Buzz Machine
To The People Andrew Sullivan Michelle Malkin Daily Kos Reason's Hit&Run The Agitator Press Think Jim Romenesko Rough Type Gawker The Graphic Truth Tail Rank Huffington Post Instapundit Little Green Footballs Talking Points Memo MoJo Blog
Seattle Stuff
Smoking. Stuff.
|

